Filter
802
Text search:
South
East
Asia
&
Western
Pacific
Featured
Recommendations
93
New Publications
186
Language
Document type
No document type
377
Studies & Reports
220
Guidelines
99
Manuals
37
Strategic & Response Plan
27
Training Material
9
Resource Platforms
9
Situation Updates
8
Fact sheets
8
Infographics
7
Online Courses
1
Countries / Regions
Global
87
South–East Asia Region
28
Philippines
18
Western Pacific Region
16
Asia
16
India
15
Myanmar / Burma
13
Africa
12
Nepal
11
Cambodia
10
Nigeria
9
Bangladesh
9
Western and Central Europe
9
Indonesia
7
Kenya
6
South Africa
6
Middle East and North Africa
6
Ethiopia
5
Afghanistan
5
Syria
5
China
5
Russia
5
Sierra Leone
4
Liberia
4
Ghana
4
Mozambique
4
Yemen
4
East and Southern Africa
4
Latin America and the Carribbean
4
Congo, Democratic Republic of
3
Somalia
3
Pakistan
3
South Sudan
3
Tanzania
3
Rwanda
3
Malawi
3
Papua New Guinea
3
West and Central Africa
3
Eastern Europe and Central Asia
3
Uganda
2
Zimbabwe
2
Thailand
2
Ukraine
2
Madagascar
2
Venezuela
2
Eastern Europe
2
Laos
2
North America
2
Guinea
1
Burkina Faso
1
USA
1
Cameroon
1
Haiti
1
Iraq
1
Zambia
1
Egypt
1
Sudan
1
Benin
1
Central African Republic
1
Vanuatu
1
Namibia
1
Peru
1
Eswatini/ Swaziland
1
Serbia
1
Colombia
1
Ecuador
1
Botswana
1
Mexico
1
Sri Lanka
1
Other region
1
Solomon Islands
1
Palestine
1
North Korea
1
Mongolia
1
Timor Leste/ East Timor
1
Moldova
1
Iran
1
Vietnam
1
Japan
1
Authors & Publishers
Publication Years
Category
Countries
133
Clinical Guidelines
102
Public Health
64
Women & Child Health
63
Key Resources
31
Pharmacy & Technologies
13
Capacity Building
12
Toolboxes
HIV
96
Mental Health
93
Planetary Health
62
COVID-19
60
Rapid Response
37
Global Health Education
35
TB
33
NTDs
27
Caregiver
26
Disability
25
AMR
25
NCDs
23
Natural Hazards
22
Refugee
15
Pharmacy
13
Conflict
11
Zika
11
Ebola
8
Health Financing Toolbox
6
Polio
4
Specific Hazards
4
Typhoon
3
Cholera
2
Social Ethics
1
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. The optimistic scenario, the report indicates, is for
...
The global emergence of antimicrobial resistance (AMR) is posing a threat to human health. Putting resources into the containment of AMR – including surveillance – is one of the highest-yield investments a country can make to mitigate its impact. In 2015, WHO launched the Global Antimicrobial Re
...
Practical actions in cities to strengthen preparedness for the COVID-19 pandemic and beyond
recommended
This document accompanies the interim guidance on “Strengthening Preparedness for COVID-19 in cities and urban settings”. It provides local authorities, leaders and policy-makers in cities with a checklist tool to ensure that key areas have been covered. An excel version that local authorities m
...
Interim guidance. 12 May 2021. The Continuity of essential health services: Facility Assessment Tool can be used by countries to rapidly assess the capacity of health facilities to maintain the provision of essential health services during the COVID-19 pandemic. It can help to alert the authorities
...
A module from the suite of health service capacity assessments in the context of the COVID-19 pandemic, Interim Guidance 20 October 2020.
This self-assessment tool is designed for acute health-care facilities (i.e. tertiary and secondary) but can be modified for the use in long-term care facilities
...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report
...
The checklist is aligned with, and builds upon, existing COVID-19-related WHO guidelines and is structured around protective measures related to: 1) hand hygiene and respiratory etiquette; 2) physical distancing; 3) use of masks in schools; 4) environmental cleaning and ventilation; and 5) respectin
...
14 January 2021
This practical guide can be used to help countries monitor and analyse the impact of COVID-19 on essential health services to inform planning and decision-making. It provides practical recommendations on how to use key performance indicators to analyse changes in access to and deliv
...
COVID-19 has heavily emphasized how contact tracing is crucial for managing outbreaks, and as part of the strategy for adjusting, and eventually lifting, lockdowns and other stringent public health and social measures. As the pandemic develops further, it will be a core measure to manage further wav
...
The framework responds to the demand from Member States and partners for guidance on how the health sector and its operational basis in health systems can systematically and effectively address the challenges increasingly presented by climate variability and change. This framework has been designed
...
Обновленная версия. В этой версии приведены обновленные рекомендации относительно стратегии диагностического тестирования в контексте обновлённой классификаци
...
The portable diagnostic imaging technology covered by this document will serve not only the pressing demands for tuberculosis screening and triage but also other diseases. Therefore, the requirements, accessories, hardware and software packages listed in the following specifications are described in
...
The 2021 WHO health and climate change global survey report provides a valuable snapshot of the overall progress governments have made in addressing the health risks of climate change. The findings on key health and climate change indicators aim to empower policy makers to: make informed decisions o
...
Taking a multisectoral, One Health approach is necessary to address complex health threats at the human-animal-environment interface, such as rabies, zoonotic influenza, anthrax, and Rift Valley fever. Such zoonotic diseases continue to have major impacts on health, livelihoods, and economies, and c
...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons
...
This document provides interim guidance to countries on testing considerations and strategies for suspect cases of severe acute hepatitis of unknown aetiology in children. It is primarily intended for clinical, programmatic, laboratory and diagnostic stakeholders across Member States and national pu
...
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults,
...
Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection
recommended
Policy Brief. 24 June 2022. This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommendations include decentralization, integration and ta
...
An overview of validation structures and responsibilities at national, regional and global levels.
This governance document supplements the global guidance document. Validation of elimination requires rigorous assessment at the national, regional and global levels of the impact and process indicato
...
Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis: learners’ guide. World Health Organization.
